Skip to main content
The peer-authored management source for clinical lab professionals since 1969.
Continuing Education
Diagnostics
Disease
Management
Molecular
Sections
Continuing Education
Diagnostics
Disease
Management
Molecular
Information Technology
Online Exclusives
Special
Magazine
Newsletter
Webinars
White Papers
eBooks
Clinical Laboratory Reference
Videos
Events
Contact
About Us
Magazine Subscription
Newsletter Subscription
Advertise
Contact Us
Affiliated Brands
HEALTHCARE PURCHASING NEWS
HEALTHCARE INNOVATION
Follow us on
https://www.facebook.com/MLOMedicalLaboratoryObserver
https://www.linkedin.com/company/medical-laboratory-observer
https://twitter.com/MedicalLabMLO
Disease
2198118127/ iStock / Getty Images Plus/Gett Images
Disease
2026 MLO State of the Industry Survey: Laboratories navigate antimicrobial resistance challenges, shifting respiratory testing trends, and ongoing supply chain pressures
The 2026 Medical Laboratory Observer (MLO) State of the Industry (SOI) Survey on Disease Management focused on antimicrobial resistance (AMR) and respiratory testing. MLO asked...
Aug. 4, 2026
By Татьяна Креминская on Adobe Stock
Cancer
New option for patients with treatment-resistant advanced melanoma: FDA’s new approval
Aug. 13, 2026
ID 166574088 © Monkey Business Images | Dreamstime.com
Disease
Rutgers expert highlights heart disease risks and prevention strategies
Aug. 11, 2026
By ChayTee on Adobe Stock
Disease
Duke Health’s real-world study addresses concerns about lecanemab
Aug. 10, 2026
By Dr_Microbe on Adobe Stock
Disease
Tonix announces FDA alignment on Phase 2 Lyme disease prevention study for TNX-4800
Aug. 10, 2026
By and.one on Adobe Stock
Flu
FDA approves Moderna’s mFLUSIVA for adults 50+ ahead of 2026-2027 flu season
Aug. 7, 2026
Courtesy of Fujirebio
Analyzers
Analyzer spotlight: A robust, mid-sized, fully automated immunoassay instrument
Aug. 7, 2026
By sukarman on Adobe Stock
Disease
CDC updates Cyclospora outbreak page: More states experiencing cases
Aug. 6, 2026
By Rawpixel.com on Adobe Stock
Artificial Intelligence
Vanderbilt’s AI initiative aims to reduce wait times for Alzheimer’s patients
Aug. 6, 2026
Looking for Something?
Load More Content